Patents by Inventor Jill M. Weimer

Jill M. Weimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTIMIZED GENE THERAPY TARGETING RETINAL CELLS
    Publication number: 20220226507
    Abstract: The present disclosure relates to methods of targeting specific cell types within the retina using optimized gene therapy vectors. In particular, the disclosure provides gene therapy vectors to specifically target retinal cells and methods of treating visual impairment, retinal degeneration and vision-related disorders such as CLN disease.
    Type: Application
    Filed: April 15, 2020
    Publication date: July 21, 2022
    Inventors: Kathrin Christine Meyer, Shibi Likhite, Brian K. Kaspar, Jill M. Weimer
  • GENE THERAPY FOR TREATING OR PREVENTING VISUAL EFFECTS IN BATTEN DISEASE
    Publication number: 20220193259
    Abstract: The present disclosure relates to gene therapy methods of preserving photoreceptors and/or inhibiting or preventing retinal degeneration in Batten disease patients, including recombinant adeno-associated vims (rAAV) delivery of a neuronal ceroid lipofuscinosis neuronal 6 (CLN6) polynucleotide.
    Type: Application
    Filed: April 15, 2020
    Publication date: June 23, 2022
    Inventors: Kathrin Meyer, Shibi Likhite, Brian K. Kaspar, Jill M. Weimer